Volitionrx (VNRX) Net Income towards Common Stockholders (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 929.05% |
| Sep 30, 2025 | -204.80% |
| Jun 30, 2025 | 100.54% |
| Mar 31, 2025 | 4.69% |
| Dec 31, 2024 | 0.48% |
| Sep 30, 2024 | 16.66% |
| Jun 30, 2024 | 16.51% |
| Mar 31, 2024 | 3.80% |
| Dec 31, 2023 | -3.92% |
| Sep 30, 2023 | 11.62% |
| Jun 30, 2023 | -7.88% |
| Mar 31, 2023 | -9,430.81% |
| Dec 31, 2022 | 35.77% |
| Sep 30, 2022 | -15.79% |
| Jun 30, 2022 | -1.99% |
| Mar 31, 2022 | 14.90% |
| Dec 31, 2021 | 62.18% |
| Sep 30, 2021 | -5.20% |
| Jun 30, 2021 | 404.45% |
| Mar 31, 2021 | -60.38% |
| Dec 31, 2020 | 195.44% |
| Sep 30, 2020 | 39.30% |
| Jun 30, 2020 | 100.10% |
| Mar 31, 2020 | -53.49% |
| Dec 31, 2019 | 8.20% |
| Sep 30, 2019 | -0.62% |
| Jun 30, 2019 | -8.23% |
| Mar 31, 2019 | 10.49% |
| Dec 31, 2018 | 4.42% |
| Sep 30, 2018 | 3.78% |
| Jun 30, 2013 | -15.39% |
| Jun 30, 2012 | -16.18% |